Immunocore (IMCR) Short Interest Ratio & Short Volume → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free IMCR Stock Alerts $58.47 +1.16 (+2.02%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immunocore Short Interest DataCurrent Short Volume4,610,000 sharesPrevious Short Volume4,290,000 sharesChange Vs. Previous Month+7.46%Dollar Volume Sold Short$299.65 millionShort Interest Ratio / Days to Cover9.4Last Record DateMarch 31, 2024Outstanding Shares49,820,000 sharesFloat Size48,570,000 sharesShort Percent of Float9.49%Today's Trading Volume386,120 sharesAverage Trading Volume483,201 sharesToday's Volume Vs. Average80% Short Selling Immunocore ? Sign up to receive the latest short interest report for Immunocore and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMCR Short Interest Over TimeIMCR Days to Cover Over TimeIMCR Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Immunocore Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,610,000 shares $299.65 million +7.5%9.5%9.4 $65.00 3/15/20244,290,000 shares $260.96 million +1.4%8.8%8.9 $60.83 2/29/20244,230,000 shares $284.34 million +9.6%8.7%8.6 $67.22 2/15/20243,860,000 shares $272.13 million +20.6%8.0%8.2 $70.50 1/31/20243,200,000 shares $231.33 million +8.1%6.6%6.7 $72.29 1/15/20242,960,000 shares $211.82 million +2.4%6.1%8 $71.56 Get the Latest News and Ratings for IMCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunocore and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,890,000 shares $197.44 million -13.0%6.0%8.4 $68.32 12/15/20233,320,000 shares $213.04 million -17.2%6.9%10.1 $64.17 11/30/20234,010,000 shares $211.45 million -3.4%8.3%13.1 $52.73 11/15/20234,150,000 shares $198.95 million +12.5%8.6%15.4 $47.94 10/31/20233,690,000 shares $163.84 million +7.3%8.0%14.2 $44.40 10/15/20233,440,000 shares $172.65 million +4.6%7.4%15 $50.19 9/30/20233,290,000 shares $170.75 million +3.8%7.1%14.9 $51.90 9/15/20233,170,000 shares $167.34 million +6.0%6.9%15.1 $52.79 8/31/20232,990,000 shares $168.25 million +4.2%6.2%15.2 $56.27 8/15/20232,870,000 shares $172.92 million +8.3%6.0%14.2 $60.25 7/31/20232,650,000 shares $174.85 million -4.7%5.8%12.8 $65.98 7/15/20232,780,000 shares $176.25 million No Change6.1%12 $63.40 6/30/20232,780,000 shares $166.69 million -4.1%6.1%11.5 $59.96 6/15/20232,900,000 shares $168.03 million +7.8%6.4%11.3 $57.94 5/31/20232,690,000 shares $148.43 million -5.0%5.7%10.2 $55.18 5/15/20232,830,000 shares $174.44 million +14.6%6.0%10.8 $61.64 4/30/20232,470,000 shares $143.38 million -1.6%5.3%9.5 $58.05 4/15/20232,510,000 shares $137.57 million +0.4%5.3%9.7 $54.81 3/31/20232,500,000 shares $123.60 million +8.7%5.3%9.5 $49.44 3/15/20232,300,000 shares $121.12 million +10.1%4.9%8.6 $52.66 2/28/20232,090,000 shares $114.64 million No Change4.5%6.9 $54.85 2/15/20232,090,000 shares $134.87 million No Change4.5%6.3 $64.53 1/31/20232,090,000 shares $128.05 million +8.9%4.5%5.8 $61.27 1/15/20231,920,000 shares $122.00 million +39.1%4.1%4.9 $63.54 12/30/20221,380,000 shares $78.76 million -28.5%3.0%3.6 $57.07 12/15/20221,930,000 shares $114.68 million +27.0%4.1%5.2 $59.42 11/30/20221,520,000 shares $95.47 million -9.5%3.3%3.9 $62.81 11/15/20221,680,000 shares $109.33 million -15.6%3.6%4.4 $65.08 10/31/20221,990,000 shares $113.71 million -13.9%5.2%6 $57.14 10/15/20222,310,000 shares $111.76 million +6.9%6.1%7.8 $48.38 9/30/20222,160,000 shares $101.39 million +27.8%5.7%7.7 $46.94 9/15/20221,690,000 shares $76.17 million +89.5%4.4%5.7 $45.07 8/31/2022891,800 shares $47.10 million -1.2%2.3%3.1 $52.81 8/15/2022902,500 shares $49.42 million -15.7%2.4%4.3 $54.76The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him IMCR Short Interest - Frequently Asked Questions What is Immunocore's current short interest? Short interest is the volume of Immunocore shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 4,610,000 shares of IMCR short. 9.49% of Immunocore's shares are currently sold short. Learn More on Immunocore's current short interest. What is a good short interest ratio for Immunocore? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMCR shares currently have a short interest ratio of 9.0. Learn More on Immunocore's short interest ratio. What is a good short interest percentage for Immunocore? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.49% of Immunocore's floating shares are currently sold short. Is Immunocore's short interest increasing or decreasing? Immunocore saw a increase in short interest in March. As of March 31st, there was short interest totaling 4,610,000 shares, an increase of 7.5% from the previous total of 4,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Immunocore's float size? Immunocore currently has issued a total of 49,820,000 shares. Some of Immunocore's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunocore currently has a public float of 48,570,000 shares. How does Immunocore's short interest compare to its competitors? 9.49% of Immunocore's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Immunocore: Arcellx, Inc. (9.85%), Apogee Therapeutics, Inc. (13.11%), SpringWorks Therapeutics, Inc. (14.45%), Iovance Biotherapeutics, Inc. (21.08%), Denali Therapeutics Inc. (8.39%), Vericel Co. (9.07%), Kymera Therapeutics, Inc. (14.83%), ImmunityBio, Inc. (41.52%), Beam Therapeutics Inc. (16.34%), Ginkgo Bioworks Holdings, Inc. (20.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Immunocore stock? Short selling IMCR is an investing strategy that aims to generate trading profit from Immunocore as its price is falling. IMCR shares are trading up $1.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunocore? A short squeeze for Immunocore occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMCR, which in turn drives the price of the stock up even further. How often is Immunocore's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMCR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Arcellx Short Squeeze Apogee Therapeutics Short Squeeze SpringWorks Therapeutics Short Squeeze Iovance Biotherapeutics Short Squeeze Denali Therapeutics Short Squeeze Vericel Short Squeeze Kymera Therapeutics Short Squeeze ImmunityBio Short Squeeze Beam Therapeutics Short Squeeze Ginkgo Bioworks Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMCR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry